Aspen Aerogels (NYSE:ASPN) Trading Down 10.4% – Time to Sell?

Aspen Aerogels, Inc. (NYSE:ASPN)’s share price fell 10.4% during trading on Wednesday . The stock traded as low as $16.58 and last traded at $16.58. 927,510 shares changed hands during trading, a decline of 38% from the average session volume of 1,504,713 shares. The stock had previously closed at $18.51.

Wall Street Analyst Weigh In

ASPN has been the topic of a number of recent analyst reports. StockNews.com raised shares of Aspen Aerogels to a “sell” rating in a research report on Thursday, October 31st. TD Cowen lifted their price objective on Aspen Aerogels from $36.00 to $41.00 and gave the stock a “buy” rating in a research note on Tuesday, August 20th. Roth Mkm reissued a “buy” rating and set a $36.00 price objective on shares of Aspen Aerogels in a research report on Wednesday, August 21st. HC Wainwright reaffirmed a “buy” rating and issued a $30.00 target price on shares of Aspen Aerogels in a report on Wednesday, October 16th. Finally, Benchmark reiterated a “buy” rating and set a $14.00 price target on shares of Aspen Aerogels in a report on Thursday, August 8th. One equities research analyst has rated the stock with a sell rating, nine have assigned a buy rating and one has given a strong buy rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $29.40.

Aspen Aerogels Stock Down 9.0 %

The business has a fifty day simple moving average of $23.58 and a two-hundred day simple moving average of $24.66. The company has a quick ratio of 2.82, a current ratio of 3.46 and a debt-to-equity ratio of 0.23. The company has a market capitalization of $1.30 billion, a price-to-earnings ratio of -1,685.00 and a beta of 2.21.

Aspen Aerogels (NYSE:ASPN) last issued its quarterly earnings results on Wednesday, August 7th. The construction company reported $0.21 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.05 by $0.16. The business had revenue of $117.80 million for the quarter, compared to the consensus estimate of $101.99 million. Aspen Aerogels had a net margin of 0.39% and a return on equity of 0.74%. The firm’s quarterly revenue was up 144.4% on a year-over-year basis. During the same quarter in the prior year, the company earned ($0.22) EPS. Equities analysts expect that Aspen Aerogels, Inc. will post 0.1 EPS for the current year.

Insider Activity at Aspen Aerogels

In other Aspen Aerogels news, CEO Donald R. Young sold 63,355 shares of Aspen Aerogels stock in a transaction on Monday, September 30th. The shares were sold at an average price of $30.03, for a total transaction of $1,902,550.65. Following the completion of the sale, the chief executive officer now owns 483,640 shares of the company’s stock, valued at approximately $14,523,709.20. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. In other Aspen Aerogels news, CEO Donald R. Young sold 63,355 shares of the company’s stock in a transaction that occurred on Monday, September 30th. The shares were sold at an average price of $30.03, for a total value of $1,902,550.65. Following the completion of the sale, the chief executive officer now owns 483,640 shares of the company’s stock, valued at approximately $14,523,709.20. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CFO Ricardo C. Rodriguez sold 32,465 shares of the business’s stock in a transaction on Monday, August 26th. The shares were sold at an average price of $30.14, for a total transaction of $978,495.10. Following the completion of the transaction, the chief financial officer now directly owns 20,790 shares of the company’s stock, valued at $626,610.60. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. 4.30% of the stock is owned by company insiders.

Institutional Inflows and Outflows

Institutional investors have recently bought and sold shares of the stock. Sargent Investment Group LLC grew its holdings in shares of Aspen Aerogels by 1.8% in the 3rd quarter. Sargent Investment Group LLC now owns 323,369 shares of the construction company’s stock valued at $8,954,000 after acquiring an additional 5,830 shares in the last quarter. Black Swift Group LLC raised its holdings in Aspen Aerogels by 34.1% in the 3rd quarter. Black Swift Group LLC now owns 106,500 shares of the construction company’s stock valued at $2,949,000 after acquiring an additional 27,100 shares during the period. Oppenheimer & Co. Inc. lifted its holdings in Aspen Aerogels by 167.2% during the 3rd quarter. Oppenheimer & Co. Inc. now owns 102,535 shares of the construction company’s stock worth $2,839,000 after purchasing an additional 64,154 shares during the last quarter. Peregrine Asset Advisers Inc. bought a new stake in shares of Aspen Aerogels in the third quarter valued at about $1,520,000. Finally, Sigma Planning Corp acquired a new position in shares of Aspen Aerogels during the 3rd quarter worth approximately $274,000. Institutional investors own 97.64% of the company’s stock.

Aspen Aerogels Company Profile

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.